tradingkey.logo

Envoy Medical Inc

COCH
0.738USD
+0.012+1.71%
Market hours ETQuotes delayed by 15 min
15.87MMarket Cap
LossP/E TTM

Envoy Medical Inc

0.738
+0.012+1.71%

More Details of Envoy Medical Inc Company

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Envoy Medical Inc Info

Ticker SymbolCOCH
Company nameEnvoy Medical Inc
IPO dateMar 02, 2021
CEOMr. Brent T. Lucas
Number of employees42
Security typeOrdinary Share
Fiscal year-endMar 02
Address4875 White Bear Parkway
CityWHITE BEAR LAKE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code55110
Phone16513618000
Websitehttps://www.envoymedical.com/
Ticker SymbolCOCH
IPO dateMar 02, 2021
CEOMr. Brent T. Lucas

Company Executives of Envoy Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
+3.35%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
+3.35%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--

Revenue Breakdown

No Data
No Data
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
NorthRock Partners, LLC
35.88%
Taylor (Glen A)
35.88%
Atlas Merchant Capital LLC
1.94%
The Vanguard Group, Inc.
1.38%
Weiss Asset Management
1.28%
Other
23.64%
Shareholders
Shareholders
Proportion
NorthRock Partners, LLC
35.88%
Taylor (Glen A)
35.88%
Atlas Merchant Capital LLC
1.94%
The Vanguard Group, Inc.
1.38%
Weiss Asset Management
1.28%
Other
23.64%
Shareholder Types
Shareholders
Proportion
Investment Advisor
39.37%
Individual Investor
37.15%
Private Equity
1.94%
Hedge Fund
1.67%
Investment Advisor/Hedge Fund
1.40%
Other
18.47%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
57
12.73M
44.52%
+8.56M
2025Q2
70
23.44M
108.95%
+6.87M
2025Q1
77
13.16M
66.71%
-3.62M
2024Q4
150
12.62M
59.27%
-33.88M
2024Q3
159
13.83M
66.11%
-35.76M
2024Q2
163
13.88M
70.79%
-37.22M
2024Q1
162
13.71M
69.92%
-38.36M
2023Q4
154
4.83M
24.67%
-35.19M
2023Q3
153
6.18M
31.55%
-33.86M
2023Q2
150
4.03M
92.35%
-36.92M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
NorthRock Partners, LLC
10.29M
46.98%
+10.29M
--
Jun 30, 2025
Taylor (Glen A)
10.29M
46.98%
--
--
Apr 10, 2025
Atlas Merchant Capital LLC
555.53K
2.54%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
394.96K
1.8%
--
--
Jun 30, 2025
Weiss Asset Management
368.14K
1.68%
-19.82K
-5.11%
Jun 30, 2025
Lucas (Brent T)
209.46K
0.96%
+7.74K
+3.84%
May 30, 2025
Focus Partners Wealth, LLC
212.66K
0.97%
--
--
Jun 30, 2025
DSG Capital Advisors, LLC
163.64K
0.75%
--
--
Jun 30, 2025
Arcus Capital Partners, LLC
187.57K
0.86%
--
--
Jun 30, 2025
Meteora Capital LLC
108.51K
0.5%
--
--
Apr 10, 2025
View more

Related ETFs

Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI